Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 79
Filtrer
1.
Front Cardiovasc Med ; 11: 1366269, 2024.
Article de Anglais | MEDLINE | ID: mdl-38504716

RÉSUMÉ

Introduction: SARS-CoV-2 infection affects the cardiopulmonary system in the acute as well as long-term phase. The aim of the present study was to comprehensively assess symptoms and possible long-term impairments 6 and 18 months after hospitalization for severe COVID-19 infection. Methods: This prospective registry included patients with PCR-confirmed COVID-19 infection requiring hospitalization. Follow-up approximately 6 months post discharge comprised a detailed patient history, clinical examination, transthoracic echocardiography, electrocardiogram, cardiac magnetic resonance imaging (cMRI), chest computed tomography (CT) scan, pulmonary function test (PFT), six-minute walk test (6MWT) and a laboratory panel. At the time of the second follow-up visit at 18 months, patients without pathologic findings during the first study visit were contacted by phone to inquire about the course of their symptoms. In all other patients all initial examinations were repeated. Results: Two hundred Patients, who were hospitalized for COVID-19, were contacted by phone and were recruited for the study. Due to dropouts the second study visit was performed in 170 patients. A comparison between the two study visits at 6 and 18 months post discharge showed the following results: Six months after discharge, 73% and 18 months after discharge 52% fulfilled the criteria for Long COVID with fatigue being the most common symptom (49%). Echocardiography at 6 months post discharge showed an impaired left ventricular function in 8% of which 80% returned to normal. Six months post discharge, cMRI revealed pericardial effusion in 17% which resolved in 47% of the 15 patients who underwent a control cMRI. Signs of peri- or myocarditis were present in 5% of the patients and were resolved in all 4 patients who attended control studies. At 6 months, chest CT scans identified post-infectious residues in 24%. In the 25 repeated chest CT scans 20% showed full recovery. Length of in-hospital stay was identified as a significant predictor for persisting Long COVID (95% CI: 1.005-1.12, p = 0.03). Conclusion: Comparing 6 to 18 months, the prevalence of Long COVID decreased over time, but a high symptom burden remained. Structural and functional abnormalities were less frequent than the portrayed symptoms, and it thus remains a challenge to substantiate the symptoms.

2.
Eur J Prev Cardiol ; 23(6): 657-67, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-26285770

RÉSUMÉ

There are large variations in the incidence, registration methods and reported causes of sudden cardiac arrest/sudden cardiac death (SCA/SCD) in competitive and recreational athletes. A crucial question is to which degree these variations are genuine or partly due to methodological incongruities. This paper discusses the uncertainties about available data and provides comprehensive suggestions for standard definitions and a guide for uniform registration parameters of SCA/SCD. The parameters include a definition of what constitutes an 'athlete', incidence calculations, enrolment of cases, the importance of gender, ethnicity and age of the athlete, as well as the type and level of sporting activity. A precise instruction for autopsy practice in the case of a SCD of athletes is given, including the role of molecular samples and evaluation of possible doping. Rational decisions about cardiac preparticipation screening and cardiac safety at sport facilities requires increased data quality concerning incidence, aetiology and management of SCA/SCD in sports. Uniform standard registration of SCA/SCD in athletes and leisure sportsmen would be a first step towards this goal.


Sujet(s)
Cardiologie/normes , Collecte de données/normes , Mort subite cardiaque/épidémiologie , Enregistrements/normes , Médecine du sport/normes , Sports/normes , Autopsie/normes , Cause de décès , Consensus , Dopage sportif , Humains , Incidence , Facteurs de risque , Détection d'abus de substances/normes , Terminologie comme sujet
3.
Scand J Med Sci Sports ; 25(4): e360-7, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-25262765

RÉSUMÉ

Downhill skiing in the elderly increases maximal oxygen uptake (VO2max) and carbohydrate handling, and produces muscle hypertrophy. We hypothesized that adjustments of the cellular components of aerobic glucose combustion in knee extensor muscle, and cardiovascular adjustments, would increase in proportion to VO2max. Nineteen healthy elderly subjects (age 67.5 ± 2.9 years) who completed 28.5 days of guided downhill skiing over 3 months were assessed for anthropometric variables, cardiovascular parameters (heart rate, hematocrit), VO2max, and compared with controls (n = 20). Biopsies of vastus lateralis muscle were analyzed for capillary density and expression of respiratory chain markers (NDUFA9, SDHA, UQCRC1, ATP5A1) and the glucose transporter GLUT4. Statistical significance was assessed with a repeated analysis of variance and Fisher's post-hoc test at a P value of 5%. VO2max increased selectively with ski training (+7 ± 2%). Capillary density (+11 ± 5%) and capillary-to-fiber ratio (12 ± 5%), but not the concentration of metabolic proteins, in vastus lateralis were increased after skiing. Cardiovascular parameters did not change. Fold changes in VO2max and capillary-to-fiber ratio were correlated and were under genetic control by polymorphisms of the regulator of vascular tone, angiotensin converting enzyme. The observations indicate that increased VO2max after recreational downhill ski training is associated with improved capillarity in a mainly recruited muscle group.


Sujet(s)
Protéines mitochondriales/métabolisme , Muscle quadriceps fémoral/vascularisation , Muscle quadriceps fémoral/métabolisme , Ski/physiologie , Adaptation physiologique , Sujet âgé , Vaisseaux capillaires/anatomie et histologie , Vaisseaux capillaires/physiologie , Complexe I de la chaîne respiratoire/métabolisme , Complexe II de la chaîne respiratoire/métabolisme , Complexe III de la chaîne respiratoire/métabolisme , Femelle , Transporteur de glucose de type 4/métabolisme , Rythme cardiaque , Hématocrite , Humains , Mâle , Mitochondrial Proton-Translocating ATPases/métabolisme , Fibres musculaires squelettiques/cytologie , Néovascularisation physiologique , Facteurs de couplage de la phosphorylation oxydative/métabolisme , Consommation d'oxygène , Peptidyl-Dipeptidase A/génétique , Polymorphisme génétique , Muscle quadriceps fémoral/anatomie et histologie
4.
Rev Sci Instrum ; 84(7): 073704, 2013 Jul.
Article de Anglais | MEDLINE | ID: mdl-23902073

RÉSUMÉ

We present an electronic circuit that allows to calibrate and troubleshoot scanning probe microscopy (SPM) controllers with respect to their noise performance. The control signal in an SPM is typically highly nonlinear-the tunneling current in scanning tunneling microscopy (STM) varies exponentially with distance. The exponential current-versus-voltage characteristics of diodes allow to model the current dependence in STM. Additional inputs allow to simulate the effects of external perturbations and the reactions of the control electronics. We characterized the noise performance of the feedback controller using the apparent topography roughness of recorded images. For a comparison of different STM controllers, an optimal gain parameter was determined by exploring settling times through a rectangular perturbation signal. We used the circuit to directly compare the performance of two types of SPM controllers used in our laboratory.

5.
Herz ; 37(5): 499-507, 2012 Aug.
Article de Allemand | MEDLINE | ID: mdl-22669312

RÉSUMÉ

Patients with type 2 diabetes mellitus and heart failure represent a relevant population in everyday practice. Several exercise training studies have documented numerous positive changes in cardiovascular risk factors, morbidity and mortality, that can only be achieved through long-term training programs of combined aerobic and strength training. This efficient and cost effective therapy should be offered to as many patients in need as possible.


Sujet(s)
Diabète de type 2/complications , Diabète de type 2/thérapie , Traitement par les exercices physiques/méthodes , Défaillance cardiaque/complications , Défaillance cardiaque/prévention et contrôle , Entraînement en résistance/méthodes , Humains
6.
Eur J Prev Cardiol ; 19(5): 1005-33, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-22637741

RÉSUMÉ

In a previous paper, as the first of a series of three on the importance of characteristics and modalities of physical activity (PA) and exercise in the management of cardiovascular health within the general population, we concluded that, in the population at large, PA and aerobic exercise capacity clearly are inversely associated with increased cardiovascular disease risk and all-cause and cardiovascular mortality and that a dose­response curve on cardiovascular outcome has been demonstrated in most studies. More and more evidence is accumulated that engaging in regular PA and exercise interventions are essential components for reducing the severity of cardiovascular risk factors, such as obesity and abdominal fat, high BP, metabolic risk factors, and systemic inflammation. However, it is less clear whether and which type of PA and exercise intervention (aerobic exercise, dynamic resistive exercise, or both) or characteristic of exercise (frequency, intensity, time or duration, and volume) would yield more benefit for each separate risk factor. The present paper, therefore, will review and make recommendations for PA and exercise training in the management of cardiovascular health in individuals with cardiovascular risk factors. The guidance offered in this series of papers is aimed at medical doctors, health practitioners, kinesiologists, physiotherapists and exercise physiologists, politicians, public health policy makers, and individual members of the public. Based on previous and the current literature overviews, recommendations from the European Association on Cardiovascular Prevention and Rehabilitation are formulated regarding type, volume, and intensity of PA and regarding appropriate risk evaluation during exercise in individuals with cardiovascular risk factors.


Sujet(s)
Activités de la vie quotidienne , Maladies cardiovasculaires/prévention et contrôle , Traitement par les exercices physiques/normes , Exercice physique/physiologie , Obésité/rééducation et réadaptation , Guides de bonnes pratiques cliniques comme sujet , Santé publique , Maladies cardiovasculaires/étiologie , Humains , Obésité/complications , Facteurs de risque
7.
Acta Psychiatr Scand ; 126(6): 467-75, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-22486584

RÉSUMÉ

OBJECTIVE: The following crossover pilot study attempts to prove the effects of endurance training through mountain hiking in high-risk suicide patients. METHOD: Participants (n = 20) having attempted suicide at least once and clinically diagnosed with hopelessness were randomly distributed among two groups. Group 1 (n = 10) began with a 9-week hiking phase followed by a 9-week control phase. Group 2 (n = 10) worked vice versa. Assessments included the Beck Hopelessness Scale (BHS), Beck Depression Inventory (BDI), Beck Scale of Suicide Ideation (BSI), and maximum physical endurance. RESULTS: Ten participants of Group 1 and seven participants of Group 2 completed the study. A comparison between conditions showed that, in the hiking phase, there was a significant decrease in hopelessness (P < 0.0001, d = -1.4) and depression (P < 0.0001, d = -1.38), and a significant increase in physical endurance (P < 0.0001, d = 1.0), but no significant effect for suicide ideation (P = 0.25, d = -0.29). However, within the hiking phase, there was a significant decrease in suicide ideation (P = 0.005, d = -0.79). CONCLUSION: The results suggest that a group experience of regular monitored mountain hiking, organized as an add-on therapy to usual care, is associated with an improvement of hopelessness, depression, and suicide ideation in patients suffering from high-level suicide risk.


Sujet(s)
Dépression/thérapie , Exercice physique/psychologie , Prévention du suicide , Adulte , Études croisées , Femelle , Humains , Mâle , Adulte d'âge moyen , Endurance physique/physiologie , Projets pilotes , Suicide/psychologie , Tentative de suicide/prévention et contrôle , Tentative de suicide/psychologie
8.
Scand J Med Sci Sports ; 21 Suppl 1: 9-22, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21679319

RÉSUMÉ

Alpine skiing is a recreational sport with high demands on the cardiovascular and neuromuscular systems. It is assumed that skiing could have positive effects on the decline in aerobic capacity, strength, and balance ability of older individuals. In a 12-week intervention study, 47 elderly subjects (age 60-76 years) were randomized into an intervention group (IG) and a control group (CG). The IG averaged 28.5 days of guided skiing during 12 weeks. Aerobic capacity, leg power, and strength as well as postural stability were tested before, immediately after, and 10 weeks after the intervention phase. VO(2 max) improved by 7.2% from Pre to Post for the IG, without any change in the CG. Jump height increased on average by 6% over the 12 weeks for the IG, while jump height for the CG deteriorated by -11.7%. Dynamic maximal strength measured in both legs increased by 16% in the IG during the 12 weeks of skiing. In the CG, it increased by 7%, without being significant. In postural ability, no differences between groups or over time were noted. It appears that, in older individuals, 12 weeks of skiing leads to a significant increase in aerobic capacity, leg muscle power, and strength.


Sujet(s)
Exercice physique/physiologie , Force musculaire/physiologie , Aptitude physique/physiologie , Équilibre postural/physiologie , Ski/physiologie , Adaptation physiologique , Facteurs âges , Sujet âgé , Vieillissement/physiologie , Analyse de variance , Femelle , Humains , Contraction isométrique/physiologie , Jambe/physiologie , Mâle , Adulte d'âge moyen , Consommation d'oxygène , Statistiques comme sujet , Statistique non paramétrique
9.
Scand J Med Sci Sports ; 21 Suppl 1: 23-8, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21679320

RÉSUMÉ

This study investigated whether regular alpine skiing could reverse sarcopenia and muscle weakness in older individuals. Twenty-two older men and women (67 ± 2 years) underwent 12 weeks of recreational skiing, two to three times a week, each session lasting ∼ 3.5 h. An age-matched, inactive group (n=20, 67 ± 4 years) served as a control (CTRL). Before and after the training period, knee extensors muscle thickness (T(m) ), pennation angle (θ) and fascicle length (L(f) ) of the vastus lateralis muscle were measured by ultrasound. Maximum isokinetic knee extensor torque (MIT) at an angular velocity of 60°/s was measured by dynamometry. After the training, T(m) increased by 7.1% (P<0.001), L(f) by 5.4% (P<0.02) and θ by 3.4% (P<0.05). The increase in T(m) was matched by a significant gain in MIT (13.3%, P<0.001). No significant changes, except for a decrease in θ (2.1%, P<0.02), were found in the CTRL group. The gain in T(m) in the training group correlated significantly with an increase in the focal adhesion kinase content, pointing to a primary role of this mechano-sensitive protein in sarcomere remodeling with muscle hypertrophy. Overall, the results show that alpine skiing is an effective intervention for combating sarcopenia and weakness in old age.


Sujet(s)
Adaptation physiologique/physiologie , Vieillissement/physiologie , Contraction musculaire/physiologie , Muscles squelettiques/physiologie , Ski/physiologie , Mise en charge/physiologie , Facteurs âges , Sujet âgé , Analyse de variance , Femelle , Humains , Mâle , Dynamomètre pour la mesure de la force musculaire , Faiblesse musculaire , Sarcopénie , Statistiques comme sujet , Moment de torsion
10.
Scand J Med Sci Sports ; 21 Suppl 1: 39-46, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21679322

RÉSUMÉ

Strain is one of the parameters determining tendon adaptation to mechanical stimuli. The aim of this study was to test whether the patellar tendon strain induced during recreational alpine skiing would affect tendon mechanical properties in older individuals. Twenty-two older males and females (67 ± 2 years) were assigned to a 12-week guided skiing programme (IG) and 20 aged-matched volunteers served as controls (CG). Patellar tendon mechanical properties and cross-sectional area (CSA) were measured before and after training, with combined dynamometry and ultrasonography scanning. None of the variables changed significantly in the CG after training. In the IG, tendon stiffness and Young's modulus were increased (respectively, 14% and 12%, P<0.01), without any significant change in tendon CSA. In addition, changes in tendon stiffness were blunted in women (9%) compared with men (19%). Serum IGF-1 concentration tended to be lower in women (-19%, P=0.07). These results demonstrate that the mechanical stimulus induced by alpine skiing is sufficient to elicit adaptive changes in patellar tendon mechanical and material properties in older subjects. Furthermore, the present sex-specific adaptations are consistent with previous reports of lower collagen metabolic responsiveness in women and may be underpinned by anthropometric and metabolic differences.


Sujet(s)
Adaptation physiologique/physiologie , Vieillissement/physiologie , Collagène/métabolisme , Ski/physiologie , Stress physiologique , Tendons/physiologie , Facteurs âges , Sujet âgé , Analyse de variance , Indice de masse corporelle , Tissu conjonctif/physiologie , Femelle , Humains , Facteur de croissance IGF-I , Mâle , Contraction musculaire/physiologie , Muscles squelettiques/physiologie , Facteurs sexuels , Statistiques comme sujet
11.
Scand J Med Sci Sports ; 21 Suppl 1: 29-38, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21679321

RÉSUMÉ

We hypothesized that 12 weeks of downhill skiing mitigates the functional deficits of knee extensor muscles in elderly subjects due to the specific recruitment of fast motor units during forceful turns on the slope. Downhill skiing led to a 1.4-fold increase in the mean cross-sectional area of slow (P=0.04)- and fast (P=0.08)-type muscle fibers. Fold changes in the expression of the structural component of focal adhesions, gamma-vinculin, were correlated with alterations in concentric force (r=0.64). Hypertrophy of fast fibers was more pronounced in women than in men (1.7 vs 1.1). Gender-specific structural-functional adjustments of knee extensor muscles and attached patellar tendon were reflected by altered expression of pro- vs de-adhesive proteins and a number of correlations. The de-adhesive protein tenascin-C was selectively increased in women compared with men (1.7 vs 1.1) while the content of the adhesive collagen XII was specifically reduced in women. The pro-adhesive focal adhesion kinase showed a specific increase in men compared with women (1.9 vs 1.1). Our findings indicate that quantitatively matched adaptations in slow and fast motor units of extensor muscle underlie the preventive effect of skiing against sarcopenia and support that hypertrophy and reinforcement of fiber adhesion operate in the improvement of muscle strength.


Sujet(s)
Vieillissement/physiologie , Contacts focaux/physiologie , Fibres musculaires à contraction rapide/physiologie , Fibres musculaires à contraction lente/physiologie , Force musculaire/physiologie , Ski/physiologie , Adaptation physiologique , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Analyse de variance , Matrice extracellulaire , Femelle , Humains , Contraction isométrique/physiologie , Mâle , Statistiques comme sujet , Ténascine , Mise en charge/physiologie
12.
Scand J Med Sci Sports ; 21 Suppl 1: 47-55, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21679323

RÉSUMÉ

Numerous studies have shown that treatment of the modifiable cardiovascular risk factors (CVRF) results in a decreased risk to suffer from stroke or myocardial infarction. Despite the fact that exercise training is a potent treatment choice for CVRF, this is the first randomized study to assess the effects of alpine skiing on CVRF in elderly skiers. Subjects (n=42) were randomized into an intervention group (IG; n=22; 12 males/10 females; age: 66.6 ± 2.1 years) completing 12 weeks of guided skiing or a control group (CG; n=20; 10 males/10 females; age: 67.3 ± 4.4 years). CVRF were assessed before and after the intervention period. No cardiovascular event occurred within a total of 795.1 h of skiing. A significant increase in exercise capacity in IG (ΔVO(2 max) : +2.0 mL/kg/min, P=0.005) but not in CG (ΔVO(2 max) : -0.1 mL/kg/min, P=0.858; IG vs CG: P=0.008) as well as a decrease in body fat mass [IG: -2.3%, P<0.0001; CG: ± 0.0%, P=0.866; IG vs CG: P<0.0001] was achieved. Blood pressure, blood lipids, heart rate and everyday physical activity remained essentially unchanged. Alpine skiing in the elderly is safe with respect to cardiovascular events, and improves some, but not all CVRF.


Sujet(s)
Vieillissement/physiologie , Maladies cardiovasculaires/anatomopathologie , Tolérance à l'effort/physiologie , Ski/physiologie , Facteurs âges , Sujet âgé , Composition corporelle , Indice de masse corporelle , Loi du khi-deux , Intervalles de confiance , Femelle , Rythme cardiaque/physiologie , Humains , Mâle , Activité motrice , Consommation d'oxygène , Facteurs de risque , Enquêtes et questionnaires
13.
Scand J Med Sci Sports ; 21 Suppl 1: 56-61, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21679324

RÉSUMÉ

Alpine skiing and ski training involves elements of static and dynamic training, and may therefore improve insulin sensitivity. Healthy men and women who where beginners/intermediate level of alpine skiing, were studied before (Pre) and immediately after (Post) 12 weeks of alpine ski training. After an additional 8 weeks a third test (retention study, Ret) was performed. The subjects were randomized into an intervention group (IG, n=22, age=66.6 ± 0.4 years) or a control group (CG, n=20, age=67.0 ± 1.0 years). Plasma glucose decreased (P<0.05) in CG, but increased (P<0.05) again at Ret, while a continued decrease was seen in IG (Ret vs Post, P<0.05). Plasma insulin decreased (P<0.05) with training in IG, while no effect was seen in CG. HOMA2 index for insulin resistance decreased (P<0.05) from 0.80 ± 0.08 to 0.71 ± 0.09 in IG. The value at Ret (0.57 ± 0.08) tended (P=0.067) to be different from Post. In CG the corresponding values were 0.84 ± 0.09, 0.81 ± 0.12 and 0.70 ± 0.09, respectively. Total cholesterol and LDL decreased in both IC and CG, a result, interpreted as seasonal variation. Biomarkers for endothelial function and low-grade inflammation were not elevated and similar in IG and CG, and did not change. Alpine ski training improves glucose homeostasis and insulin sensitivity in healthy, elderly individuals.


Sujet(s)
Vieillissement/physiologie , Marqueurs biologiques , Maladies cardiovasculaires/anatomopathologie , Endothélium vasculaire/anatomopathologie , Glucose/métabolisme , Ski/physiologie , Facteurs âges , Sujet âgé , Composition corporelle , Test ELISA , Exercice physique/physiologie , Femelle , Homéostasie , Humains , Lipides/sang , Mâle , Force musculaire/physiologie , Aptitude physique , Facteurs de risque , Statistique non paramétrique , Facteurs temps
14.
Diabetes Obes Metab ; 12(9): 825-8, 2010 Sep.
Article de Anglais | MEDLINE | ID: mdl-20649635

RÉSUMÉ

We conducted a three-arm, parallel-group, randomized, controlled trial to compare the effects of rosiglitazone and physical exercise on endothelial function in patients with coronary artery disease and impaired fasting glucose or impaired glucose tolerance over a 6-month period. Group A received rosiglitazone tablets 8 mg daily (n = 16), group B underwent a structured physical exercise programme (n = 15) and group C served as a control group (n = 12). At baseline and after 6 months, brachial artery ultrasound imaging was performed to assess reactive flow-mediated dilation (FMD). Rosiglitazone treatment and exercise both led to significant improvements in insulin resistance at 6 months, whereas no change was observed in control patients. FMD improved significantly in physical exercise patients, whereas no change could be observed in patients receiving rosiglitazone or in the control group. Between-group comparisons also showed a significant relative improvement in FMD in exercise patients compared with rosiglitazone.


Sujet(s)
Maladie des artères coronaires/traitement médicamenteux , Traitement par les exercices physiques/méthodes , Hypoglycémiants/pharmacologie , État prédiabétique/traitement médicamenteux , Thiazolidinediones/pharmacologie , Glycémie/métabolisme , Artère brachiale/effets des médicaments et des substances chimiques , Artère brachiale/physiologie , Maladie des artères coronaires/physiopathologie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Endothélium vasculaire/physiologie , Jeûne/sang , Femelle , Humains , Hypoglycémiants/administration et posologie , Insulinorésistance/physiologie , Mâle , Adulte d'âge moyen , État prédiabétique/physiopathologie , Rosiglitazone , Thiazolidinediones/administration et posologie , Résultat thérapeutique
15.
Clin Res Cardiol ; 97(6): 364-70, 2008 Jun.
Article de Anglais | MEDLINE | ID: mdl-18247076

RÉSUMÉ

AIM: Diabetes mellitus is associated with a poor prognosis due to a high rate of coronary artery disease. It was the aim of this survey to assess the prevalence of an impaired glucose tolerance and manifest diabetes mellitus in patients with coronary artery disease (CAD). METHODS: We analyzed data of all German centers participating in the Euro Heart Survey on diabetes and the heart, an European-wide multicenter prospective observational study. Participating centers were asked to recruit patients >18 years with a diagnosis of CAD. RESULTS: In Germany, 261 patients with a diagnosis of CAD were enrolled in five participating centers. Patients were divided into an acutely (22,4%; n = 57) or electively admitted (77,6%; n = 198) group. There were 34% (n = 89) of patients with already known diabetes. In 36% (n = 22 of 56) of the patients without previously known diabetes, an oral glucose tolerance test (OGTT) was performed (3%, n = 5 in the acute and 33%, n = 51 in the elective group). As a result, 39% (n = 22 of 56) of these patients had an impaired glucose tolerance (acute group: 0%, n = 0 of 5; elective group: 43%, n = 22 of 51) and in 13% (n = 7 of 56) diabetes mellitus was diagnosed (acute group: 40%, n = 2 of 5; elective group: 10%, n = 5 of 51). Furthermore, on admission 86% of women and 94% of men reported to exercise less than three times per week and thus less than recommended in current guidelines. CONCLUSION: More than one third of the patients with CAD who underwent an OGTT had an impaired glucose tolerance. Implementation of this simple, effective and inexpensive test into clinical routine of patients with CAD would help diagnose diabetes mellitus and thus grant these high risk patients access to an optimal medical, interventional and surgical therapy. Furthermore, patients ought to be encouraged to include exercise training into their daily routine.


Sujet(s)
Glycémie/métabolisme , Maladie des artères coronaires/complications , Diabète , Exercice physique , Enquêtes de santé , Sujet âgé , Algorithmes , Maladie des artères coronaires/métabolisme , Diabète/diagnostic , Diabète/épidémiologie , Diabète/thérapie , Femelle , Allemagne/épidémiologie , Hyperglycémie provoquée , Humains , Mâle , Adulte d'âge moyen , Études prospectives
16.
Dtsch Med Wochenschr ; 131(6): 253-7, 2006 Feb 10.
Article de Allemand | MEDLINE | ID: mdl-16463227

RÉSUMÉ

BACKGROUND AND OBJECTIVE: Because of the rising life expectancy in the industrialized countries, ever more cardiac catheterizations are performed in patients aged 80 years or older. Little is known about the incidence of peri-interventional events in this age group. PATIENTS AND METHODS: Between January 1996 and September 2000, a total of 1,085 patients of that age (mean 82.6 +/- 2.6 years) underwent cardiac catheterization and intervention (3% of a total of 43,517 cardiac catheterizations). RESULTS: 827 patients (77%) had significant coronary artery stenoses. 373 of them (45%) were treated with balloon angioplasty, with or without stenting, and 331 (40%) underwent aortocoronary bypass procedures. 31 patients died while in hospital, 17 of them having been in cardiogenic shock on admission. Peri-interventional events, including damage to artery at the site of catheter entry occurred in 2.1% of patients undergoing diagnostic cardiac catheterization and in 11.6% in connection with a percutaneous interventional procedure. CONCLUSION: Both cardiac catheterization and interventional procedures can be done with a justifiable risk in patients aged 80 years or older. These cardiac investigations/interventions should not be withheld in this group of patients for reasons of age.


Sujet(s)
Cathétérisme cardiaque/statistiques et données numériques , Sténose coronarienne/épidémiologie , Sténose coronarienne/thérapie , Facteurs âges , Sujet âgé de 80 ans ou plus , Angine de poitrine/thérapie , Angor instable/thérapie , Angioplastie coronaire par ballonnet/effets indésirables , Angioplastie coronaire par ballonnet/mortalité , Angioplastie coronaire par ballonnet/statistiques et données numériques , Artères/traumatismes , Cathétérisme cardiaque/effets indésirables , Cathétérisme cardiaque/mortalité , Pontage aortocoronarien/effets indésirables , Pontage aortocoronarien/mortalité , Pontage aortocoronarien/statistiques et données numériques , Femelle , Humains , Mâle , Infarctus du myocarde/thérapie , Pronostic , Facteurs de risque , Choc cardiogénique/épidémiologie , Choc cardiogénique/mortalité , Choc cardiogénique/thérapie , Endoprothèses/effets indésirables , Endoprothèses/statistiques et données numériques , Syncope/thérapie
17.
Z Kardiol ; 94(8): 510-5, 2005 Aug.
Article de Anglais | MEDLINE | ID: mdl-16049652

RÉSUMÉ

UNLABELLED: It was the aim of the Euro Heart Survey on Heart Failure to assess whether patients are being treated according to current guidelines. METHODS: In Germany, patients were screened in 7 medical centers if their discharge diagnoses were myocardial infarction, a new episode of atrial fibrillation, or diabetes mellitus. Patients were enrolled if at least one additional criterion was fulfilled: (1) clinical diagnosis of heart failure, (2) hospital admission due to heart failure within the last 3 years, (3) therapy with loop diuretic, (4) medication for heart failure or ventricular dysfunction documented by echocardiography within the past 24 hours prior to death. RESULTS: 2166 patients were screened of whom 747 were included in the study (478 men, 269 women). 93% of the patients suffered from heart failure. Despite the high number of patients with known heart failure (ischemic heart failure in 71%), only 72% received ACE inhibitors and 62% beta-blockers. Average daily dose met recommendations in only 63% of patients on ACE inhibitors and 54% on beta-blockers. 74% of the patients received diuretics (furosemide 36%, thiazide 34%, spironolactone 17%). CONCLUSION: An inadequately low number of patients with heart failure receives medical therapy according to guidelines, despite all the overwhelming evidence for improved morbidity and mortality. Awareness of physicians needs to be improved.


Sujet(s)
Agents cardiovasculaires/usage thérapeutique , Adhésion aux directives , Défaillance cardiaque/traitement médicamenteux , Dysfonction ventriculaire gauche/traitement médicamenteux , Antagonistes bêta-adrénergiques/usage thérapeutique , Facteurs âges , Sujet âgé , Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique , Inhibiteurs des canaux calciques/usage thérapeutique , Diurétiques/usage thérapeutique , Association de médicaments , Europe , Femelle , Fibrinolytiques/usage thérapeutique , Enquêtes de santé , Défaillance cardiaque/diagnostic , Défaillance cardiaque/étiologie , Défaillance cardiaque/mortalité , Humains , Mâle , Adulte d'âge moyen , Réadmission du patient , Guides de bonnes pratiques cliniques comme sujet , Facteurs sexuels , Inhibiteurs du symport chlorure potassium sodium/usage thérapeutique , Statistiques comme sujet , Analyse de survie , Dysfonction ventriculaire gauche/diagnostic , Dysfonction ventriculaire gauche/étiologie
19.
Dtsch Med Wochenschr ; 129(24): 1385-9, 2004 Jun 11.
Article de Allemand | MEDLINE | ID: mdl-15188092

RÉSUMÉ

Diabetes mellitus is a major risk factor for coronary artery disease and is associated with accelerated disease progression and adverse prognosis. Although relief of symptoms can quickly be obtained by percutaneous intervention or bypass surgery, it does not change patients' prognoses, with the exception of stenoses of the left main stem or left anterior descending artery. A multifactorial intervention, which consists of a low-fat diet, glucose and arterial blood pressure control, smoking cessation and regular physical exercise, emerges as an alternative strategy since it leads to improvement of the modifiable risk factors, exercise tolerance and quality of life.


Sujet(s)
Maladie coronarienne/thérapie , Diabète de type 2/thérapie , Angiopathies diabétiques/thérapie , Angioplastie coronaire par ballonnet/méthodes , Pontage aortocoronarien , Maladie coronarienne/prévention et contrôle , Humains , Lipides/sang , Pronostic , Endoprothèses
20.
Herz ; 26(2): 119-28, 2001 Mar.
Article de Allemand | MEDLINE | ID: mdl-11349614

RÉSUMÉ

BACKGROUND: Despite the use of intracoronary stents, approximately 15-20% of patients who undergo percutaneous transluminal coronary angioplasty (PTCA) experience symptomatic restenosis. Known mechanisms of restenotic lesion formation are smooth muscle cell proliferation, extracellular matrix production, remodeling and decreased programmed cell death (apoptosis). RESULTS AND STUDIES: Experimental observations suggest that HMG-CoA reductase inhibitors ("statins") reduce the risk of restenosis. The activity of statins limits the rate of synthesis, not only of cholesterol, but also of a range of other molecules involved in cellular function. Their benefits in primary and secondary prevention of atherosclerosis have been widely recognized. Clinical trials using different types of statins were designed to evaluate their ability to influence the incidence of restenosis after successful conventional PTCA. The results clearly demonstrated that statins reduce lipid levels but do not prevent restenosis. Experimental evidence has failed to translate into clinical effect. The underlying pathological reasons for this shortcoming as well as promising alternative approaches including vascular gene therapy and brachytherapy will be discussed in this review.


Sujet(s)
Angioplastie coronaire par ballonnet , Anticholestérolémiants/usage thérapeutique , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique , Hypolipémiants/usage thérapeutique , Angioplastie coronaire par ballonnet/effets indésirables , Animaux , Curiethérapie , Cholestérol/sang , Thérapie génétique , Humains , Lovastatine/usage thérapeutique , Prévention primaire , Lapins , Essais contrôlés randomisés comme sujet , Récidive , Facteurs de risque , Simvastatine/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE